New breakthrough bee vaccine technology could help combat colony declines

Beekeepers across the U.S. got a nasty surprise this year. Millions of pollinating bees were dead, with reports coming in across the country. Now, one company specializing in honeybee health says it might have a solution to the problem.

Georgia-based Dalan Animal Health says recent colony losses have created big challenges for keepers and farmers, which is why they have developed a vaccine. It exposes quee bees to inactive diseases, allowing them to give immunity to the rest of the hive. Developers have been testing the vaccine since 2022 in over 200 hives.

New numbers show commercial beekeepers lost around 62 percent of the nation’s pollinating supply over the winter. Keepers at Project APIS-M found several issues are causing the drop, including parasites and a lack of food. Honeybees help fertilize 75 percent of the world’s supplies.

LATEST STORIES BY THIS AUTHOR:

USDA released the November WASDE Report on Friday, the first supply-and-demand estimate to drop since September, just before the 43-day government shutdown.
U.S. Trade officials announced new deals with El Salvador, Guatemala, Ecuador, and Argentina, as well as a steep reduction in tariffs on Swiss imports.
China’s cost advantage with Brazilian soybeans and vague public messaging leave U.S. export prospects uncertain heading into winter.
Expanded aerial capacity strengthens the U.S.–Mexico buffer against screwworm, providing cattle producers with stronger protection heading into winter and reducing risk to herds along the southern tier.
AFBF economist Faith Parum breaks down the potential impact of the proposed policy change to allow year-round sales of E15 biofuel.